Review of PFAS health evidence and clinical guidance reported in a National Academies committee report
National Academies of Sciences, Engineering, and Medicine · The National Academies Press · 2022 · 10.17226/26156 · Guidance · Link only
The committee rated evidence as sufficient for associations between PFAS exposure and decreased antibody response, dyslipidemia, decreased infant and fetal growth, and kidney cancer, and as limited for several other outcomes, and issued recommendations on exposure assessment and blood testing.
What this document covers
The committee rated evidence as sufficient for associations between PFAS exposure and decreased antibody response, dyslipidemia, decreased infant and fetal growth, and kidney cancer, and as limited for several other outcomes, and issued recommendations on exposure assessment and blood testing.
Link only. We reproduce none of the document text; the scope line above is our own.
Source
- Review of PFAS health evidence and clinical guidance reported in a National Academies committee report · The National Academies Press · Read at the source
Last reviewed September 23, 2026.
Related reading
- Trihalomethane exposure in drinking water measured against bladder cancer in a pooled analysis of six case-control studies
- Blood lead concentration measured against intellectual function in a pooled analysis of seven cohorts
- Drinking water contaminant release and odor measured across six PEX pipe brands and a six-month-old PEX plumbing system
- Review of drinking water nitrate and health outcomes reported in an updated epidemiologic review
- Review of arsenic in drinking water reported in a National Research Council subcommittee update
- Review of fluoride in drinking water reported in a National Research Council committee assessment